Demand for organs-on-chips is expected to skyrocket in the coming years, especially as many governments are starting to limit animal testing for developing drugs and pharmaceutical products. According to a press release by Polaris Market Research, the drug discovery segment is the number one consumer of organ-on-chip technology, as they use it to replicate human organ functions while developing medicines. However, other industries are increasingly interested in the use of this technology.
